A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Closing the Data Abstraction Gap To Improve Screening Quality Metrics
The chief medial information officer and quality reporting specialist from NCH Healthcare System provides an insightful webinar designed to equip healthcare professionals with practical strategies to enhance screening rates and improve patient outcomes. This session focuses on leveraging electronic medical record tools to streamline screening referrals, addressing data abstraction gaps and evaluating the best screening options tailored to local resources
Scaling a Patient-Centric Shared Decision-Making Program Across the Network to Improve Colorectal Cancer Screening Rates
In February 2022, Beth Israel Lahey Health identified an opportunity to pilot a patient-centric shared decision-making project to engage patients in their healthcare, improve screening rates and help alleviate burdens on providers who were faced with a significant colonoscopy backlog. Tim Carey, project manager, Beth Israel Lahey Health Performance Network, will discuss how to launch a shared decision-making pilot program and the supportive role of external collaborators to drive success.
Corporate Brand Anthem
Watch this video to learn more about Exact Science’s ambition for early cancer detection, prevention and tailored treatments sets comprehensive standards